Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

FuelCell Energy May Never Be Profitable, but FCEL Stock Is Still Up Big

By Mark R. Hake, CFA

FuelCell Energy may never be profitable, but FCEL stock is still up big. FCEL stock continues to move higher on speculation about the benefits of the new RNG tax credit.

Fisker Stock Is On Track To Double Over the Next Year or So

By Mark R. Hake, CFA

Fisker stock is on track to double over the next year or so. FSR stock is worth between $30.38 and $32.75, or over twice its price today.

XpresSpa Is Trying To Turn Around, But Its Legs and Arms Are Tied

By Mark R. Hake, CFA

XpresSpa is trying to turn around, but it's tied. XSPA stock won’t be able to turn around until the company can start recognizing revenue.

Hertz Shares Are Worthless, so Don’t Be Tempted

By Mark R. Hake, CFA

Hertz stock really is worthless, so don't be lured into buying it. Hertz stock will likely have no underlying value and be worthless when the restructuring is finished.

Lexicon Pharma Sold LXRX Stock to Weight Watchers’ Turn-Around Billionaire

By Mark R. Hake, CFA

Lexicon Pharma sold LXRX stock to Weight Watchers' turn-around billionaire. Lexicon sold 15% of LXRX stock to Ray Debbane’s private equity company which turned Weight Watchers around.

Alibaba Stock Is a Bargain at One-Third the PE Ratio of Amazon Stock

By Mark R. Hake, CFA

Buy Alibaba now that it has dipped on news that won't affect its business. Baba stock is a great bargain now that it has fallen and trades for just one-third the forward P/E ratio of Amazon.

CAAS Stock Offers Good Value as Supplier to Chinese EVs and Autos

By Mark R. Hake, CFA

CAAS stock offers good value to buyers of Chinese EVs and autos. China Automotive Systems stock offers a bargain entry point into the growth of the Chinese EV market.

10 Million Reasons AYRO Stock Should Be up 31% by May

By Mark R. Hake, CFA

EV maker AYRO has 10 million reasons to get AYRO stock up 31% by May 2021. AYRO stock needs to rise above $8.09 for AYRO Inc. to receive $10 million via its first set of warrants.

Dividend Bumps and Buybacks Give Pfizer Stock 20% Upside

By Mark R. Hake, CFA

Pfizer’s dividend yield and other value metrics imply good upside for PFE stock. PFE stock is still at least 22% undervalued based on its dividend yield and other valuation metrics.

Kaixin Auto Appointed Firm That May Be Banned From Auditing Chinese Firms

By Mark R. Hake, CFA

Kaixin appointed an auditor that may be banned by the U.S. PCOAB from auditing Chinese firms. KXIN stock is even more confusing using a potentially banned auditor – implying investors should stay away.

Load More